An extreme low carbohydrate, high-fat regimen called the ketogenic diet may improve the effectiveness of an emerging class of cancer drugs, finds a study in mice by investigators at Weill Cornell Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian. In the work, scientists provide a possible explanation for why the drugs, which target the insulin-activated… Read more